Psychiatry and Clinical Psychopharmacology

Psychiatry and Clinical Psychopharmacology (formerly  Bulletin of Clinical Psychopharmacology 1996-2016) is an international, scientific, open access, online-only periodical published in accordance with independent, unbiased, and double-blinded peer-review principles. The journal is published quarterly in March, June, September, and December. The publication language of the journal is American English.
 
The aim of the journal is to bridge the gap between basic and clinical application by publishing high quality research in psychiatry and clinical psychopharmacology. The scope of the journal includes but not limited to psychiatry, child and adolescent psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry, neuroimaging, artificial intelligence, machine learning, neuronal networks, and related sciences. Psychiatry and Clinical Psychopharmacology accepts research articles, reviews, case reports, letters to the editors, editorials, and short communications/brief reports.  
 
The target audience of the journal includes specialists, residents, and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry, and related disciplines.

Psychiatry and Clinical Psychopharmacology is currently indexed in Science Citation Index Expanded, Scopus, Embase, HINARI, Proquest: Proquest Psychology Journals, Proques Health&Medical Complete, PsychINFO, PsycSCAN: Psychopharmacology, EBSCO, and Chemical Abstracts (CAS).
 
The editorial and publication processes of the journal are shaped in accordance with the guidelines of the International Committee of Medical Journal Editors (ICMJE), World Association of Medical Editors (WAME), Council of Science Editors (CSE), Committee on Publication Ethics (COPE), European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal is in conformity with the Principles of Transparency and Best Practice in Scholarly Publishing (doaj.org/bestpractice).

Publication Fee Policy
Authors should pay a one-time article processing charge (APC) to cover the costs of peer review administration and management, production of articles in PDF and to other publishing functions. There are no surcharges based on the length of an article, figures or supplementary data. In order to cover publication costs, the standard APC for Psychiatry and Clinical Psychopharmacology is $590 (including taxes).
Please note that all submissions are evaluated by the Editorial Board and external reviewers in terms of scientific quality and ethical standards. APC payments have no effect on the outcome of the article’s evaluation and/or publication priority.
Account holder name: 26688848 - AVES Yayıncılık Ltd. Şti.
Bank name: Halkbank/Gayrettepe
Account: 0850 53870964
IBAN no: TR19 0001 2009 8500 0053 8709 64
 
Advertisement Policy 
Psychiatry and Clinical Psychopharmacology can publish advertisement images in the journal’s website upon the approval of the Editor in Chief. Potential advertisers should contact the Editorial Office. Advertisers have no effect on the editorial decisions or advertising policies.

Disclaimer
Statements or opinions expressed in the manuscripts published in the journal reflect the views of the author(s) and not the opinions of the editors, editorial board, and/or publisher; the editors, editorial board, and publisher disclaim any responsibility or liability for such materials.
 
Open Access Statement
Psychiatry and Clinical Psychopharmacology is an open access publication, and the journal’s publication model is based on Budapest Access Initiative (BOAI) declaration. All published content is available online, free of charge at www.psychiatry-psychopharmacology.com. The journal’s content is licensed under a Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International License which permits third parties to share and adapt the content for non-commercial purposes by giving the appropriate credit to the original work.   

Editor in Chief: 
Mesut Cetin, M.D.
Professor of Psychiatry
Address: Bagdat Caddesi Birgen Plaza   226/7  Kadikoy 34728 Istanbul, Turkey 
Mobile: & Whatsapp:  +90-532-272-3252  
E-mail address: psikofarmakoloji@gmail.com  

Publisher: 
AVES
Address
: Büyükderece Cad., 105/9 34394 Şişli, İstanbul, Turkey
Phone: +90 212 217 17 00
Fax: +90 212 217 22 92
E-mail address: info@avesyayincilik.com
Webpage: www.avesyayincilik.com 


 

EISSN 2475-0581